Ra­dio­phar­ma CD­MOs nav­i­gate sup­ply chain, raw ma­te­r­i­al chal­lenges as de­mand goes nu­clear

No­var­tis re­cent­ly said that sales of its ra­dio­phar­ma­ceu­ti­cal Plu­vic­to came in low­er than ex­pect­ed in the third quar­ter as a re­sult of man­u­fac­tur­ing is­sues, un­der­scor­ing …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER